Here's why Medibank Private will fall after tomorrow's IPO

After all the hype surrounding an initial public offering has cleared, investors see a company for what it truly is. That's why tomorrow's Medibank Private Ltd (ASX:MPL) IPO could go the way of Freelancer Ltd (ASX:FLN) or Monash IVF Group Ltd (ASX:MVF).

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With the Australian share market up 34% in the past three years, the government has made easy work of floating its $5.7 billion health insurer, Medibank Private Ltd (ASX:MPL), which is set to debut on the Australian Securities Exchange tomorrow.

Despite many calling the float price of $2.15 overvalued, the market will be abuzz with excitement when the company's shares hit the ASX tomorrow at noon.

However, the company lacks the growth potential of its smaller rival, NIB Holdings Ltd (ASX: NHF) and will be forced to cut costs in order to improve margins and achieve forecasts.

However it appears investors aren't concerned by the unappealing prospects moving forward and are tightly focused on the potential for a stag profit. That is, an immediate jump in price on the first day of trading.

Let's just hope for those short-term sellers, there's enough buyers to get out in a hurry.

Unfortunately, at $2.15 per share, Medibank will be trade at 23 times forecast net profit in 2015 – 2016 and will pay an interim dividend of just 4.9 cents, or 2.2% in September 2015.

As a result I doubt many investors will be licking their lips at the opportunity to buy shares, particularly when you can buy the faster growing NIB for less than 19 times forecast profit.

Indeed after the all the hype surrounding the Medibank Initial Public Offering (IPO) has past, it could go the way of 2013's most exciting IPO, Freelancer Ltd (ASX: FLN). During its IPO in November 2013, the offer price of 50 cents produced a huge stag profit. However, after the immediate jump, its share price has fallen to just $0.55 today.

More likely, Medibank will go the way of Monash IVF Group Ltd (ASX: MVF). It debuted at $1.85 then spiked to $1.97 shortly after listing. This morning it opened at $1.41.

Many analysts have said a good price to buy Medibank shares is between $1.55 and $1.70. When they go on the market at $2.15 tomorrow we could the share price pop but as Freelancer and Monash IVF have shown, it might not stay there for long.

Motley Fool Contributor Owen Raszkiewicz has registered for Medibank shares and owns shares of NIB Holdings Limited.     

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »